Investment
Features
FeesSafety
Academy
More
Pluang+

Vera Therapeutics reports strong Phase III trial results and early commercial demand for kidney treatment.

Market News
15 Sep 2026
Seeking Alpha
View Source
Bullish
Vera Therapeutics reports strong Phase III trial results and early commercial demand for kidney treatment.

Vera Therapeutics announced positive final results from their pivotal Phase III trial showing significant efficacy in kidney function improvement. About 10 weeks into their first commercial launch, the company has received over 350 patient prescriptions, indicating strong early demand. They plan to present these data at the upcoming ASN kidney conference and aim for full regulatory approval by mid-2027 through a supplemental Biologics License Application (sBLA) submission in Q4 2026. This marks a major milestone for Vera and patients awaiting new kidney treatment options.

Vera Therapeutics' recent pivotal Phase III trial results and early commercial launch are notable alongside the current health sector market snapshot on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Sep 16, 2026 03:25 WIB: out of 91 priced US health-sector stocks, 55 rose and 36 fell. Key movers include TXG (10X Genomics Inc) at USD 74.50 with a +6.26% change, ADMA (ADMA Biologics Inc) at USD 8.58 with a -6.13% change, and AMWL (American Well Corp) at USD 13.76 with a +5.85% change.

More News

Evolution Petroleum posts mixed Q4 results with adjusted loss but revenue beats estimates

Evolution Petroleum posts mixed Q4 results with adjusted loss but revenue beats estimates

Evolution Petroleum reported a fiscal Q4 adjusted loss of $0.02 per share, missing the $0.01 estimate, but revenue rose 15% to $24.21 million, beating expectations. GAAP net income was $4.61 million, up from $3.41 million a year earlier, helped by un...

Company Fundamentals
Neutral
4 hours ago
Stocks FTFT, SWMR, ENVA, and leveraged ETFs fall sharply due to corporate and market factors

Stocks FTFT, SWMR, ENVA, and leveraged ETFs fall sharply due to corporate and market factors

Shares of Future FinTech Group (FTFT) dropped 28.61% after reversing previous gains, following a recent reverse stock split. Swarmer (SWMR) declined 28.36% as its post-IPO lock-up period expired, increasing potential share supply. Enova International...

Market News
Bearish
4 hours ago
Veea Inc. jumps 149% on potential business combo with NovaGen amid market slump

Veea Inc. jumps 149% on potential business combo with NovaGen amid market slump

Veea Inc. shares surged 149.34% following the announcement of a potential business combination with NovaGen Group B.V. The deal aims to create NovaGen Health Networks, merging Veea's AI edge-computing tech with NovaGen's regenerative medicine. GeoNov...

Market News
Bullish
4 hours ago
Injective's real-world asset perpetual markets hit $215M volume in 30 days, showing strong growth in onchain derivatives.

Injective's real-world asset perpetual markets hit $215M volume in 30 days, showing strong growth in onchain derivatives.

Injective's real-world asset (RWA) perpetual markets have reached $214.9 million in trading volume over the past 30 days, marking a 3.4x increase since May 2026. These perpetual contracts allow traders to hold leveraged positions on equities, commodi...

Protocol Fundamentals
Bullish
4 hours ago
XRP logo to be permanently displayed on Louisville basketball court in new Ripple deal

XRP logo to be permanently displayed on Louisville basketball court in new Ripple deal

Ripple has signed a multi-year partnership with the University of Louisville to place the XRP logo permanently on the basketball court at the KFC Yum! Center, home to both men’s and women’s basketball teams. The deal includes additional branding acro...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App